Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Varying Technology and Application Trends Pep up the Mature Research Antibodies Market Finds Frost & Sullivan - Pockets of growth and opportunities are available despite budgetary constraints that are likely for the next four years - ClinicalDiagnostics.frost.com
Varying Technology and Application Trends Pep up the Mature Research Antibodies Market Finds Frost & Sullivan

 

PRZOOM - /newswire/ - Mountain View, CA, United States, 2012/08/30 - Pockets of growth and opportunities are available despite budgetary constraints that are likely for the next four years - ClinicalDiagnostics.frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

A large competitor base and fluid market share has kept the research antibodies market highly competitive despite its maturity. Low entry barriers, large market size, and easy original equipment manufacturer (OEM) opportunities attract a wide variety of companies to this market. As research antibodies vary in quality by company, type, and even lot, customer satisfaction is hard to achieve. This translates to considerable chances for suppliers to capture market shares if they develop higher quality products.

New analysis from Frost & Sullivan's (clinicaldiagnostics.frost.com) Strategic Analysis of the U.S. Research Antibodies Market research finds that the market earned revenues of $672.0 million in 2011 and estimates this to reach $775.0 million in 2016. This anticipated expansion is due to the high growth of various antibody-based technologies as well as the continued need for basic protein research.

If you are interested in more information on this research, please send an email to Britni Myers, Corporate Communications, at britni.myers[.]frost.com, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.

Many technologies and applications that require antibodies come with their own set of dynamics and growth metrics. While some of these technologies continue to grow well, others have reached maturity and are in the process of phasing out. This results in a marketplace subject to a variety of growth factors, with surges in certain hot applications and research fields.

"Researchers use antibodies in a multitude of technologies that vary by age, popularity, ease-of-use, expense, throughput, and data output," said Frost & Sullivan Senior Industry Analyst Christi Bird. "These technologies enable applications in numerous research fields, tying growth in the research antibodies market to technology and application trends within the academic research and pharmaceutical communities."

Apart from a chaotic marketplace, the economic downturn since the end of 2008 has kept growth down to the low single digits. Consequent to the slowdown, budgetary concerns and inadequate government funding of biomedical research have made researchers cautious about their spending on laboratory products. Inflation levels in biomedical research are estimated to be around 3 percent, creating greater budget constraints for researchers each year. As the research antibodies market relies heavily on the academic sector, its growth will be greatly limited for the next two years.

Growth analyses of the top competitors in the market determined that suppliers are growing at varying rates and thus, market shares are likely to change considerably over the next five years. In addition, researchers' ranking of overall experience with suppliers differs greatly from the ranking of market shares, indicating substantial prospects for reputed suppliers.

"The competitive landscape of the market is expected to be very different in the next five years, with various companies growing much faster than the overall market," said Bird. "This points to pockets of growth and opportunities for well-positioned companies to be more successful in this market, driving growth beyond the overall market compound annual growth rate of 2.9 percent between 2011 and 2016."

Strategic Analysis of the U.S. Research Antibodies Market is part of the Life Sciences Growth Partnership Services program, which also includes research in the following markets:

• Purchasing Trends in the Research Antibodies Market: Evaluating Budgets, Suppliers, and Unmet Needs;
• Frost & Sullivan 2011 Survey of Sequencing Technologies: Instrument Adoption on the Rise as Affordable Systems Enter the Market;
• Strategic Analysis of the U.S. Next-Generation Sequencing Services Market: A Convergence of Favorable Market Dynamics;
• Global Protein Purification Reagents Market: An Expanding Role in Biopharmaceutical; Diagnostics; and Basic Biomedical Research.

All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion | Join Us: Join our community | Subscribe: Newsletter on "the next big thing" | Register: Gain access to visionary innovation.

Strategic Analysis of the U.S. Research Antibodies Market / NA8F-55

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Varying Technology and Application Trends Pep up the Mature Research Antibodies Market Finds Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan |
Contact: Britni Myers 
210-477-8481 britni.myers[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com

Visit  Triggr & Bloom







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today